Xencor Appoints Raymond Deshaies to Board of Directors to Bolster Drug Development Efforts

Xencor has appointed Raymond Deshaies to its board of directors, bringing extensive experience in biotechnology and drug development. His appointment is expected to bolster Xencor's efforts in advancing its pipeline of XmAb drug candidates through clinical development. Analysts rate XNCR stock as a Buy with a $38.00 price target.

Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, has appointed Raymond J. Deshaies, Ph.D., to its board of directors. Deshaies, a pioneering biochemist and cell biologist with over 25 years of experience in biotechnology and drug development, brings a wealth of expertise to the board.

Prior to joining Xencor, Deshaies served as senior vice president of global research at Amgen Inc., where he oversaw all research activities, including the nomination of over 50 clinical candidates, expansion of Amgen’s capabilities for discovering and optimizing multispecific drug candidates, and application of generative protein design to biologics discovery. He completed his tenure at Amgen as a distinguished fellow.

Deshaies’ appointment is expected to bolster Xencor’s efforts in advancing its pipeline of XmAb drug candidates through clinical development. Xencor’s XmAb engineering technology enables small changes to a protein’s structure that result in new mechanisms of therapeutic action.

“Ray holds a deep understanding of biological mechanisms and has a long track-record of translating cutting-edge scientific insights into transformative medicines for patients,” said Bassil Dahiyat, Ph.D., president and chief executive officer at Xencor. “We welcome Ray to our Board and look forward to his contributions as we advance our pipeline of novel XmAb® drug candidates through clinical development.”

Analysts have rated XNCR stock as a Buy with a $38.00 price target [2].

References:
[1] https://www.businesswire.com/news/home/20250731140486/en/Xencor-Appoints-Raymond-Deshaies-Ph-D-to-Board-of-Directors
[2] https://www.stocktitan.net/news/XNCR/xencor-appoints-raymond-deshaies-ph-d-to-board-of-p7wuet5jeggr.html